Coripharma, an Icelandic pharmaceutical company founded in 2018 by former employees of Actavis and investors, has secured over $15-million dollars in funding by a syndicate over 20 new investors. The pharmaceutical firm specializes in the manufacturing and development of pharmaceuticals for other pharmaceutical companies, as well as focusing on their own development. The first generic drug under the Coripharma brand is expected to be launched later in 2020.
| Website | http://www.coripharma.is |
| Revenue | $17.7 million |
| Employees | View employees |
| Address | 78 80 Reykjavikurvegur, Hafnarfjoerdur, Capital Region, IS |
| Phone | +354 420 6700 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Boehringer Ingelheim, Bavarian Nordic, Novavax, EcoVadis, SOPHiA GENETICS, CureVac, Valneva, VBI Vaccines Inc., Agnitio - A Bigtincan Company, Valiant Pharma Equipments +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Coripharma employee's phone or email?
Coripharma Questions
The Coripharma annual revenue was $17.7 million in 2026.
Coripharma is based in Hafnarfjoerdur, Capital Region.
The NAICS codes for Coripharma are [32541, 325, 32, 3254].
The SIC codes for Coripharma are [283, 28, 2834].
